Taiwan calls for fair access to vaccines amid COVID spike By Reuters

4/4
© Reuters. A medical worker guides people on how to get a rapid test following a surge of coronavirus disease (COVID-19) infections in Taipei, Taiwan, May 19, 2021. REUTERS/Ann Wang

2/4

TAIPEI (Reuters) – Taiwan’s government has called for fair access to COVID-19 vaccines during a meeting with senior Western diplomats, as it faces a dwindling supply of shots during a spike in domestic infections.

Taiwan has reported almost 1,000 new infections during the past week or so, leading to new curbs in the capital, Taipei, and shocking a population that had become accustomed to life carrying on almost normally.

But its stock of vaccines is rapidly falling. It has only received a little more than 300,000 to date, all from AstraZeneca (NASDAQ:) Plc. At least two-thirds of those have been distributed.

Taiwan’s Centres for Disease Control said in a statement on Wednesday after a virtual workshop on vaccines on Tuesday with the top U.S., British, Japanese and Australian diplomats in Taipei that nowhere was immune from the pandemic’s threat unless everyone controls it.

“Fair access to effective vaccines is the ultimate means to curb the global COVID-19 pandemic. We look forward to more effective and sufficient vaccine development and marketing, and call on all countries to work together to end the COVID-19 pandemic,” it said.

Taiwan is mobilising its diplomats to try to speed up access to more vaccines, and is in talks with the United States for a share of the COVID-19 shots President Joe Biden plans to send abroad.

Christensen, the de facto U.S. ambassador to Taiwan, said at the same event that “talking about COVID-19 vaccines can be a sensitive subject”, according to a copy of his remarks published by his office.

“We recognise that each country and region is at different stages in their COVID-19 vaccination programmes,” the remarks said. “Unfortunately, many still face difficulties gaining access to vaccines.”

Taiwan has ordered 20 million doses, mostly from AstraZeneca but also from Moderna (NASDAQ:) Inc, though global shortages have curtailed supplies.

The government says more vaccines are on the way, and hopes domestically developed shots can start being rolled out before the end of July.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*